Skip to content
MatchScript
Menu

Head-to-head · The Match Score

Alan Meds vs RxSpan MD

Both scored on the same six-factor Match Score. Alan Meds wins this matchup with a 86 to 85 edge — a photo finish.

Higher Match Score

Alan Meds

#7 · Grade B+

Budget shoppers who want an oral/sublingual route without giving up nationwide access.

Visit Alan Meds
VS

RxSpan MD

#12 · Grade B

Patients who prioritize maximum formulary breadth and verification over the lowest price.

Visit RxSpan MD

Factor by factor

The six sub-scores behind each Match Score. The quiz reweights these to your priorities — one provider can pull ahead for you on the factors you care about.

Budget Fit
93
70
Speed to Start
88
88
Formulary Match
86
94
Support Level
82
86
Flexibility
84
86
Transparency
80
88

Price, coverage & formulary

DetailAlan MedsRxSpan MD
Semaglutide$99/mo$249/mo
Tirzepatide$145/mo$329/mo
CoverageAll 50 statesAll 50 states
Brand-name accessCompounded onlyYes
Oral / sublingualYesYes
Match Score86 · B+85 · B
Winner: Alan Meds

Alan Meds edges out RxSpan MD, 86 to 85 on the default Match Score. Low double-digit sema pricing, an oral option, and all-50-state reach — a strong value pick for the needle-averse.

RxSpan MD is still a fair pick if its strengths line up with yours — best for: Patients who prioritize maximum formulary breadth and verification over the lowest price.

Worth a look either way: our overall #1 pick is CoreAge Rx (Match Score 91) — nationwide access, both molecules at one flat price, easy to cancel. Or take the 6-question quiz to see your personalized match.

Assume any provider we list may compensate us, at no cost to you. It never changes the Match Score.

Full Alan Meds reviewFull RxSpan MD review

More head-to-heads

Or browse alternatives to Alan Meds and all comparisons.

Pricing, states and verification reflect each provider's public disclosures at last review; the Match Score and its sub-scores are our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.